These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28878924)

  • 1. Serpentine supravenous hyperpigmentation.
    Jamalpur I; Mogili HR; Koratala A
    Clin Case Rep; 2017 Sep; 5(9):1546-1547. PubMed ID: 28878924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serpentine supravenous hyperpigmentation related to carboplatin and vinorelbine chemotherapy: A case report.
    Akyurek FT; Sari N; Ugurluoglu C; Kurtipek GS
    Dermatol Ther; 2019 Jul; 32(4):e12981. PubMed ID: 31168954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL.
    Lancman G; Steinberg A; Gabrilove J
    Int J Hematol Oncol Stem Cell Res; 2018 Jan; 12(1):1-3. PubMed ID: 29951170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Docetaxel-induced supravenous serpentine dermatitis.
    Ghosh SK; Bandyopadhyay D; Ghoshal L; Basu S
    Dermatol Online J; 2011 Nov; 17(11):16. PubMed ID: 22136872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent serpentine supravenous hyperpigmented eruption in lepromatous leprosy after minocycline.
    Narang T; Dogra S; Sakia UN
    Lepr Rev; 2015 Jun; 86(2):191-4. PubMed ID: 26502692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent serpentine supravenous hyperpigmentation--a possible cutaneous manifestation of HIV infection or a normal racial variant: a report of 3 cases.
    O'Malley JT; Lieb JL; Weiser JA; Grossman ME
    Skinmed; 2013; 11(2):93-4. PubMed ID: 23745227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent serpentine supravenous hyperpigmented eruption associated with docetaxel.
    Aydogan I; Kavak A; Parlak AH; Alper M; Annakkaya AN; Erbas M
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):345-7. PubMed ID: 15857462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serpentine supravenous hyperpigmentation induced by chemotherapy: a systematic review.
    Shan J; Obiakor BC; Cheng J; Francois RA; Dobry AS
    Arch Dermatol Res; 2024 May; 316(6):215. PubMed ID: 38787426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serpentine Supra-venous Hyperpigmentation "Badge of Courage" in Fight Against Cancer: An Brief Review.
    Narayan S; Talwar V; Redhu P; Goel V; Jain A; Soni S; Chaudhary K; Basu D
    Gulf J Oncolog; 2022 Sep; 1(40):83-87. PubMed ID: 36448076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine.
    Marcoux D; Anex R; Russo P
    J Am Acad Dermatol; 2000 Sep; 43(3):540-6. PubMed ID: 10954672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles.
    Suvirya S; Agrawal A; Parihar A
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25336557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
    Lau JF; Dean SM; Rooke TW; Olin JW
    Vasc Med; 2016 Dec; 21(6):558-559. PubMed ID: 27197682
    [No Abstract]   [Full Text] [Related]  

  • 14. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
    Rao R; Balachandran C
    Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
    [No Abstract]   [Full Text] [Related]  

  • 15. Serpentine supravenous hyperpigmentation induced by docetaxel.
    Das A; Kumar D; Mohanty S; Mondal AK; Chowdhury SN; Bandyopadhyay D
    Indian J Dermatol Venereol Leprol; 2015; 81(4):434. PubMed ID: 25937137
    [No Abstract]   [Full Text] [Related]  

  • 16. Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine.
    Claudy AL; Lévigne V; Boucheron S
    Dermatology; 1992; 184(1):70-2. PubMed ID: 1559000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpentine supravenous hyperpigmentation resulting from vinorelbine administration.
    Roach EC; Petekkaya I; Gezgen G; Ünlü O; Altundag K
    Breast J; 2015; 21(3):311-2. PubMed ID: 25808569
    [No Abstract]   [Full Text] [Related]  

  • 18. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
    Chan CC; Lin SJ
    N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
    [No Abstract]   [Full Text] [Related]  

  • 19. Serpentine supravenous streaks induced by 5-fluorouracil.
    Jain V; Bhandary S; Prasad GN; Shenoi SD
    J Am Acad Dermatol; 2005 Sep; 53(3):529-30. PubMed ID: 16112371
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
    Hrushesky WJ
    JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.